A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HIV-1 / human immunodeficiency virus type 1

[Related PubMed/MEDLINE]
Total Number of Papers: 15921
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HIV-1  (>> Co-occurring Abbreviation)
Long Form:   human immunodeficiency virus type 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies. ---
2021 A "Two-Birds-One-Stone" Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region. NHR
2021 A Background Assessable and Correctable Bimolecular Fluorescence Complementation System for Nanoscopic Single-Molecule Imaging of Intracellular Protein-Protein Interactions. BAC-BiFC, BiFC, FP, PPIs, SMLM
2021 A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner. HBV
2021 A Hepatitis B Virus-Derived Peptide Exerts an Anticancer Effect via TNF/iNOS-producing Dendritic Cells in Tumor-Bearing Mouse Model. CD8, CTL, DCs, HBV, iNOS, NO, TNF-alpha
2021 A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. ATI, cp, IL-2, IQR, TNF-alpha
2021 A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid. CA, ESI-MS, RT
2021 A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome. ARS, CI, hAHI, IP
2021 A transient heritable memory regulates HIV reactivation from latency. LRAs
10  2021 Abortive HIV-1 RNA induces pro-IL-1β maturation via protein kinase PKR and inflammasome activation in humans. PKR
11  2021 Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses. Hu-mouse, NHP
12  2021 Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients. ASCVD, CIMT, CVD, ISG56
13  2021 Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120. i.c.v
14  2021 An assessment of the reproducibility of reverse transcription digital PCR quantification of HIV-1. dPCR, EQA, IU, RT-dPCR, RT-qPCR
15  2021 An insight on promising strategies hoping to cure HIV-1 infection by targeting Rev protein-short review. ART, FDCs, INIs, NNRTIs, NRTIs, PIs
16  2021 An Overview of Human Immunodeficiency Virus-1 Antiretroviral Drugs: General Principles and Current Status. HAART
17  2021 Antisense Transcripts and Antisense Protein: A New Perspective on Human Immunodeficiency Virus Type 1. ASP, ORF
18  2021 Antivirals that target the host IMPα/β1-virus interface. 4-HPR, IMP, NS5, RCTs, WNV
19  2021 Applying frequency chaos game representation with perceptual image hashing to gene sequence phylogenetic analyses. FCGR, HEV, PIH
20  2021 Asymptomatic Human Immunodeficiency Virus-1 Infection with High CD4+ T Cell Count Does Not Alter Iron Metabolism or Hepcidin Levels: The Pilot Study. ART, hs-CRP, IL-6, sTfR, VL
21  2021 Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis. cART
22  2021 B Lymphocytes, but Not Dendritic Cells, Efficiently HIV-1 Trans Infect Naive CD4+ T Cells: Implications for the Viral Reservoir. APC, ART, DC, NP, TN
23  2021 Balance between Retroviral Latency and Transcription: Based on HIV Model. AIDS, ART, LTR
24  2021 Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeutic targets. SIV
25  2021 Broad and potent bispecific neutralizing antibody gene delivery using adeno-associated viral vectors for passive immunization against HIV-1. BibNAbs, bNAbs, iMab, rAAV8, scFv
26  2021 CG Dinucleotide Removal in Bioluminescent and Fluorescent Reporters Improves HIV-1 Replication and Reporter Gene Expression for Dual Imaging in Humanized Mice. CG, iRFP, Nluc
27  2021 Chemical Characterization and Anti-HIV-1 Activity Assessment of Iridoids and Flavonols from Scrophularia trifoliata. IN, RNase H
28  2021 Cholesterol Modulates the Interaction between HIV-1 Viral Protein R and Membrane. SSNMR, Vpr
29  2021 Circulating fibroblast growth factor-2 precipitates HIV nephropathy in mice. FGF-2, HIVAN, p-ERK, rAd-FGF-2
30  2021 Classification and Design of HIV-1 Integrase Inhibitors Based on Machine Learning. IN, NB, RP
31  2021 Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion. IRF3, PI, PR, TBK1
32  2021 COMPARATIVE ANALYSIS OF qPCR MEASUREMENT OF HIV VIRAL LOAD AND ELISA DETECTION OF p24 ANTIGEN AFTER HYPERBARIC OXYGEN EXPOSURE. ELISA, PBMCs, qPCR
33  2021 Components of apoptotic pathways modulate HIV-1 latency in Jurkat cells. FasL
34  2021 Comprehensive Analysis of Human Cytomegalovirus- and HIV-Mediated Plasma Membrane Remodeling in Macrophages. HCMV, IFN, PM
35  2021 Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children. ADCC, NAb, PBMC
36  2021 CPI-637 as a Potential Bifunctional Latency-Reversing Agent That Targets Both the BRD4 and TIP60 Proteins. HAART, LRAs, LTR, P-TEFb, SEC
37  2021 CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats. LTR
38  2021 Cross-Neutralizing CRF01_AE-Infected Plasma from Malaysia Targets CD4-Binding Site of Human Immunodeficiency Virus Type-1 Envelope Glycoprotein. bNAbs
39  2021 Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation. Env
40  2021 Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner. CPSF6, CypA
41  2021 Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression. CycT1, DUBs, P-TEFb, TAR, Tat
42  2021 Development of a Bio-Layer Interferometry-Based Protease Assay Using HIV-1 Protease as a Model. BLI, PR
43  2021 Disassembling the Nature of Capsid: Biochemical, Genetic, and Imaging Approaches to Assess HIV-1 Capsid Functions. ---
44  2021 Disruption of HIV-1 co-receptors CCR5 and CXCR4in primary human T cells and hematopoietic stemand progenitor cells using base editing. ---
45  2021 Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen. 5-aza-C, FeLV, MuLV
46  2021 Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants. AIDS, RMSD
47  2021 Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment. ARV, DTG, MMPs
48  2021 Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. CI, NRTIs
49  2021 Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold. HERV-K, JSRV, MMTV
50  2021 Dual-targeted anti-CMV/anti-HIV-1 heterodimers. CMV
51  2021 Effect of Different Nuclear Localization Signals on the Subcellular Localization and Anti-HIV-1 Function of the MxB Protein. ISGs, MxB, NLS
52  2021 Eliminating HIV reservoirs for a cure: the issue is in the tissue. GI
53  2021 Elucidating the Antiviral Mechanism of Different MARCH Factors. MARCH, MLV
54  2021 Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application. AIDS, bNAbs
55  2021 Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies. aa, ADCC, bNAbs, CD4bs, FcgammaR, HIV, NK
56  2021 Epidemiological and phylogenetic analysis for non-B subtypes of human immunodeficiency virus type 1 in Busan, Korea. MSM
57  2021 Evolutionary Genetics of Mycobacterium tuberculosis and HIV-1: "The Tortoise and the Hare". ---
58  2021 Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. CPPs, HSV-1, NLS, pI
59  2021 Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces. AFAD
60  2021 Extracellular vesicles regulate gap junction-mediated intercellular communication and HIV-1 infection of human neural progenitor cells. CNS, Cx43, EV-Abeta, EVs, GJ, HAND, HBMEC, hNPCs, p-Cx43, Panx2
61  2021 Fejerlectin, a Lectin-like Peptide from the Skin of Fejervarya limnocharis, Inhibits HIV-1 Entry by Targeting Gp41. ---
62  2021 First complete-genome documentation of HIV-1 intersubtype superinfection with transmissions of diverse recombinants over time to five recipients. ---
63  2021 FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat. TF
64  2021 Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK-8507, an Investigational, Oral, Once-Weekly Nonnucleoside Reverse Transcriptase Inhibitor. CI, EPA
65  2021 Functional Anatomy of the Trimer Apex Reveals Key Hydrophobic Constraints That Maintain the HIV-1 Envelope Spike in a Closed State. ---
66  2021 Genetic Characterization of a Novel HIV-1 Second-Generation Recombinant Form Originating from CRF86_BC and a Unique Recombinant Form in Yunnan, China. URF
67  2021 Genome editing in large animal models. DMD, NHPs
68  2021 Glucose-dependent aerobic glycolysis contributes to recruiting viral components into HIV-1 particles to maintain infectivity. ---
69  2021 GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration. AEA, FAAH, HAND, MCM
70  2021 Graves' Disease in a Patient With Human Immunodeficiency Virus Infection as an Immune Reconstitution Inflammatory Syndrome. ART, GD, HAART, IRIS
71  2021 Harnessing Natural Mosaics: Antibody-Instructed, Multi-Envelope HIV-1 Vaccine Design. AIDS
72  2021 HIV Infection and Related Mental Disorders. CNS
73  2021 HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development? cART
74  2021 HIV-1 Entry and Membrane Fusion Inhibitors. Env
75  2021 HIV-1 Entry and Prospects for Protecting against Infection. T/F
76  2021 HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles. Env, smFRET
77  2021 HIV-1 exposure promotes PKG1-mediated phosphorylation and degradation of stathmin to increase epithelial barrier permeability. Pkg1
78  2021 HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity. ---
79  2021 HIV-1 Nef-Induced Secretion of the Proinflammatory Protease TACE into Extracellular Vesicles Is Mediated by Raf-1 and Can Be Suppressed by Clinical Protein Kinase Inhibitors. EVs, Hck, MAPK, SIV, TACE
80  2021 HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of Curcuma aeruginosa Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening. AIDS, PR, RT
81  2021 HIV-1 uses dynamic podosomes for entry into macrophages. ---
82  2021 HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4+ T Cells Early Postinfection. ---
83  2021 HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits. cART, DA
84  2021 HIV-associated neurotoxicity and cognitive decline: Therapeutic implications. ART, HAD, HAND
85  2021 HIV-Infected Macrophages Are Infected and Killed by the Interferon-Sensitive Rhabdovirus MG1. AM, MDM
86  2021 hsa-miR-191-5p inhibits replication of human immunodeficiency virus type 1 by downregulating the expression of NUP50. ART, miRNAs, qPCR
87  2021 Human Immunodeficiency Virus (HIV) and Human Cytomegalovirus (HCMV) Coinfection of Infant Tonsil Epithelium May Synergistically Promote both HIV-1 and HCMV Spread and Infection. HCMV, HIV, MAPK, MTCT
88  2021 Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System. CNS, HAND, HIV
89  2021 Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning. TRIM5alpha
90  2021 Huntingtin-Interacting Protein 1 Promotes Vpr-Induced G2 Arrest and HIV-1 Infection in Macrophages. HIP1
91  2021 Identification of a new 2-amino acid insertion in the integrase coding region of HIV-1 subtype G isolates. IN, INSTIs
92  2021 Identification of a New HIV-1 BC Intersubtype Circulating Recombinant Form (CRF108_BC) in Spain. CRFs
93  2021 Identification of a Novel Cis-Acting Regulator of HIV-1 Genome Packaging. Psi
94  2021 Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding Site. CSPs, FIV, NMR
95  2021 Imaging Viral Infection by Fluorescence Microscopy: Focus on HIV-1 Early Stage. PIC, vDNA, vRNA
96  2021 Immunocompetent Human 3D Organ-Specific Hormone-Responding Vaginal Mucosa Model of HIV-1 Infection. GFP, MDMs
97  2021 Immunogenicity Evaluation of N-Glycans Recognized by HIV Broadly Neutralizing Antibodies. bNAbs
98  2021 Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size. ---
99  2021 Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques. ALFA
100  2021 Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates. NNRTI, NRTI, RAMs